Aug 25, 2016 20:05 pm UTC| Business
— Both pivotal Phase 3 studies now published in leading infectious disease journals — — FDA and EMA currently reviewing marketing applications for solithromycin for CABP in U.S. and EU — CHAPEL HILL, N.C., Aug. 25,...
uniQure Announces Financial Results For Second Quarter 2016 and Update on Company Progress
Aug 25, 2016 20:05 pm UTC| Business
~ Progress Across the Pipeline~ Additional data on AMT-060 in Hemophilia B Expected Later this Year~Data from Sanfilippo B and Parkinson’s Disease Studies Expected in Q1 2017~Strong Balance Sheet to Support Advancement of...
Micron Technology Announces Upcoming Investor Events
Aug 25, 2016 20:05 pm UTC| Business
BOISE, Idaho, Aug. 25, 2016 -- Micron Technology, Inc. (NASDAQ:MU) Chief Financial Officer Ernie Maddock will present at the following webcasted investor conferences: Thursday, Sept. 8 at 10:15 a.m. EDT, at the Citi...
Bottomline Announces Stock Repurchase Program
Aug 25, 2016 20:02 pm UTC| Business
PORTSMOUTH, N.H., Aug. 25, 2016 -- Bottomline Technologies (NASDAQ:EPAY), a leading provider of cloud-based business payment, invoice and banking solutions, today announced that its Board of Directors has authorized a...
Bottomline Technologies Reports Fourth Quarter and Fiscal Year 2016 Results
Aug 25, 2016 20:01 pm UTC| Business
PORTSMOUTH, N.H., Aug. 25, 2016 -- Bottomline Technologies (NASDAQ:EPAY), a leading provider of cloud-based business payment, invoice and digital banking solutions, today reported financial results for the fourth...
rue21, inc. to Host Investors Conference Call on Second Quarter 2016 Financial Results
Aug 25, 2016 20:01 pm UTC| Business
WARRENDALE, Pa., Aug. 25, 2016 -- rue21, inc. (the “Company”) today announced that it will hold an investor conference call to review its second quarter and year to date 2016 financial results on Thursday, September...
Intellipharmaceutics to Present at the 18th Annual Rodman & Renshaw Global Investment Conference
Aug 25, 2016 20:00 pm UTC| Business
TORONTO, Aug. 25, 2016 -- Intellipharmaceutics International Inc.(Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of...